Asia / TAIWAN
To continue to view the full report
Buy this company's report, or subscribe to a plan.
Company Overview
Intech Biopharm Ltd. engages in the development of drugs for obstructive airway diseases such as bronchial asthma and chronic obstructive pulmonary disease. Its products include HFA metered dosage inhaler; respiratory drugs; and oncology drugs. The company was founded on October 28, 2010 and is headquartered in Taipei, Taiwan.
Intech Biopharm Ltd. engages in the development of drugs for obstructive airway diseases such as bronchial asthma and chronic obstructive pulmonary disease. Its products include HFA metered dosage inhaler; respiratory drugs; and oncology drugs. The company was founded on October 28, 2010 and is headquartered in Taipei, Taiwan.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Pharmaceutical Preparations |
| Country | TAIWAN |
| Employees | 82 |
| Reporting Unit | Billions |
| Primary Exchange | Unknown exchange |
| Instrument Type | Equity |
| Website | http://www.intechbiopharm.com |
| Wright ID | C158DKPHF |
Key Metrics
| Current price | $27.50 |
| Market cap | $3.03 B |
| P/E ratio | n/a |
| 52-week perf. | +1.6% |
| Common shares | 110.3 M |
| Share type | Gu |
| Quality rating | DLL0 |
| Dividend yield | 0.00% |
Recent stock performance
| 1 Week | +2.0% |
| 4 Week | +4.0% |
| 13 Week | +8.3% |
Officers
| Chairman | Chih-Hui Lin |
| Finance Director | Jiawei Zhou |
Address
Ruiguang Road
TAIPEI
TAIWAN
114
| Phone | n/a |
Quarterly Earnings & Dividends
Quarterly earnings and dividend history is not available for this company.
Try another report for annual statements, Wright Quality history or comparative analysis.